6505--Compounded Chemotherapy
ID: 36C26224Q1704Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF262-NETWORK CONTRACT OFFICE 22 (36C262)Gilbert, AZ, 85297, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs (VA) is soliciting quotes for a firm-fixed price Indefinite Quantity Indefinite Delivery (IDIQ) contract to supply compounded chemotherapy medications for the VA Long Beach Healthcare System in California. Vendors are required to provide a comprehensive list of specified chemotherapy drugs, ensuring compliance with safety and quality standards, including a minimum of 12 hours remaining on the Beyond-Use Date for all products. This procurement is crucial for maintaining effective patient care and access to essential medications, with the contract performance period expected to span from October 2024 through September 2029. Interested parties must submit their proposals by September 9, 2024, at 10:00 AM Pacific Time, and direct any inquiries to Hestia Sim at Hestia.Sim@va.gov.

    Point(s) of Contact
    Hestia SimContract Specialist
    Hestia.Sim@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs is soliciting quotes for a firm-fixed price Indefinite Quantity Indefinite Delivery (IDIQ) contract, under solicitation number 36C26224Q1704, for the supply of compounded chemotherapy medications. The contract will serve the VA Long Beach Healthcare System, requiring that vendors provide all specified medications from FDA-compliant facilities. This procurement is unrestricted and open to commercial suppliers, with a response deadline set for September 9, 2024. Vendors must supply a comprehensive list of chemotherapy drugs, ensuring delivery meets rigorous safety and quality standards, including a minimum of 12 hours remaining on the Beyond-Use Date. The contractor’s pharmacy must hold valid licenses and adhere to strict packaging, labeling, and temperature monitoring requirements during transport. The agreement emphasizes the importance of prompt notification of product recalls or safety issues. Vendors are advised to register on SAM.gov for eligibility, and communication regarding the RFP should be directed to the provided contact, Hestia Sim. The expected performance period spans from October 2024 through September 2029, inclusive of potential option years. The contract aligns with federal procurement regulations, reflecting the VA's commitment to patient care through accessing essential medications efficiently and securely.
    The Department of Veterans Affairs seeks a vendor for a firm-fixed-price contract to supply and deliver compounded chemotherapy medications to the VA Long Beach Healthcare System. The contract, with a base year and four option years, aims to ensure a steady supply of these vital medications for patient care. Vendors must have a certified 503A pharmacy licensed to operate within California and comply with USP 797 standards. The comprehensive medication list includes brands and generics, such as Humira, Epogen, and Velcade, requiring precise handling and timely delivery. Responses to the solicitation are due by 10:00 AM on August 20, 2024. The government emphasizes the need for prompt delivery, with routine orders delivered by 6:00 AM PST the day of treatment and emergency orders same-day.
    This government document is an amendment to a previous combined solicitation (Solicitation Number: 36C26224Q1704) regarding the procurement of compounded chemotherapy for the Department of Veterans Affairs (VA). The amendment addresses two key changes: it releases an updated solicitation document and extends the response deadline to September 9, 2024, at 10:00 AM Pacific Time. Offerors must acknowledge this amendment and resubmit their proposals based on the updates. The contract falls under Product Service Code 6505 and NAICS Code 325412, indicating its focus on pharmaceuticals. The execution of services will occur at the VA Long Beach Healthcare System's pharmacy in California. Additional contact information is provided for Hestia Sim, facilitating communication for interested parties. This amendment highlights the VA's ongoing commitment to updating procurement opportunities while ensuring compliance with established terms and conditions.
    The document details a Request for Quotation (RFQ) from the VA for compounded chemotherapy services, identified by the primary ID 36C26224Q1704. It outlines specifications for billing rates, item descriptions, and relevant certifications required from vendors, including Environmental Attributes and Controlled Substance considerations. The RFQ is structured with various sections encompassing pricing information, packaging details, delivery instructions, and necessary compliance codes such as NAICS, UNSPSC, and SIC codes. Key elements also include a contact for inquiries, specifics on order quantities, and the need for vendors to provide documentation verifying their adherence to federal standards. Emphasis is placed on potential environmental impacts through green product evaluations, while hazardous material management is outlined to ensure safe handling. The purpose of this RFQ is to procure vital pharmacy services within a specified timeframe while ensuring compliance with health and safety regulations. This initiative underscores the VA's commitment to providing safe and effective healthcare solutions through qualified vendors.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Calcitonin Gene-Related Peptides (CGRP) through its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract that ensures a consistent supply of these pharmaceutical products while adhering to federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). The CGRP products are critical for various medical treatments within VA facilities, emphasizing the importance of quality control and reliable delivery. Interested offerors must submit their proposals by November 7, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0050 760-25-1-050-0022 - Leavenworth CMOP AMLODIPINE (VA-25-00014183)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) facility in Leavenworth, Kansas, under solicitation number 36C77025Q0050. The procurement includes a range of medications, with specific quantities and packaging requirements, emphasizing compliance with the Drug Supply Chain Security Act and the Buy American statute. This initiative is crucial for ensuring a reliable supply of essential medications for veteran care services. Interested vendors must submit their quotes, including a signed SF1449 cover page, a price schedule in Excel format, and a state wholesale distributor license, by November 6, 2024, with an anticipated award date of November 13, 2024. For further inquiries, vendors can contact Jeffrey Blackard at Jeffrey.Blackard@va.gov or (913) 684-0142.
    Simplifi 797 and Simplifi+Medstorage or Equal
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, is seeking quotes for the procurement of Simplifi 797 and Simplifi+ MedStorage or equivalent software to enhance compliance with U.S. Pharmacopeial Convention (USP) standards for sterile compounding. The required software must provide a web-based quality management system that automates compliance with USP 795, 797, and 800 standards, while also facilitating necessary training and documentation for pharmacy staff to adhere to storage protocols and quality assurance practices in medication management. This acquisition is critical for maintaining high standards in medication safety and quality control, with quotes due by November 5, 2024, and the contract spanning a base period of one year with four additional option periods. Interested vendors should submit detailed quotes electronically, including past performance references and pricing, to Caleb Parker at caleb.parker@va.gov or by phone at (713) 791-1414 ext. 149866.
    Q517--Omnicell New Preventative Maintenance Service Package
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) Network Contracting Office 19 intends to award a sole source Fixed Price Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Omnicell, INC. for the provision of preventative maintenance and support for the Omnicell Medication Supply Station and System. This contract will include enhancements such as the addition of new software and capabilities, ensuring the operational efficiency of the medication dispensing systems critical to healthcare services. Interested firms may submit written notifications demonstrating their ability to meet the requirements by November 14, 2024, at 10:00 AM Mountain Standard Time, with all responses directed to Contract Specialist David Glanton at david.glanton@va.gov. Contractors must be registered in the System for Award Management (SAM) to be eligible for consideration, and the estimated period of performance for this contract is from February 1, 2025, to January 31, 2028.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0052 770-25-1-801-0071 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking bids for an emergency procurement of Ferrous Sulfate 324MG EC Tablets, specifically packaged in bottles of 100, to be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The procurement requires a total of seven different quantities ranging from 1,200 to 9,600 units, with a delivery timeframe of 10 days after receipt of order (ARO). This initiative is crucial for maintaining a reliable pharmaceutical supply chain to support the healthcare needs of veterans. Interested vendors must submit their proposals by November 6, 2024, at 9:00 AM CST, including a signed SF1449 cover page, a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate, with the estimated award date set for November 12, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--Radiopharmaceuticals VA San Diego Base Year Only
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide radiopharmaceuticals for the VA San Diego Healthcare System, as outlined in a Sources Sought Notice. This procurement aims to gather information on potential sources capable of meeting the requirements specified under NAICS code 325412, with a focus on ensuring compliance with federal regulations and safety standards. The contract is anticipated to be a firm-fixed-price indefinite quantity arrangement, valued at approximately $350,000 for the base year, with responses due by November 4, 2024. Interested parties should submit their capabilities statements and relevant information to Contracting Officer Adrienne Brown at adrienne.brown4@va.gov.
    6505--VA Northern California Health Care System VA Medical Center - Martinez Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide radiopharmaceuticals and radiopharmaceutical supplies for the VA Northern California Health Care System, specifically for the VA Medical Center in Martinez. The procurement aims to ensure a reliable supply of essential radiopharmaceuticals for diagnostic and therapeutic procedures, with a focus on quality control and compliance with federal regulations. This contract spans five ordering periods from April 1, 2025, to March 31, 2030, with a guaranteed minimum award of $100 and a maximum aggregate order limit of $1,200,000. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov for further details.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.